Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypericin-PDT in Peritoneal Carcinosis
NCT02840331Phase 3Unknown
- Sponsor
- University Hospital Tübingen
- Start
- Jul 2017
- Primary completion
- Dec 2019
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of hypericin in peritoneal carcinomatosis (PC), gastric cancer (GC), sponsored by University Hospital Tübingen. Status: unknown.
02
Drugs
hypericin
03
Conditions
peritoneal carcinomatosis (PC)gastric cancer (GC)
Beyond the preview
Go deeper on NCT02840331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02840331.